[1] |
Blay JY, Kang YK, Nishida T, et al. Gastrointestinal stromal tumours [J]. Nat Rev Dis Primers, 2021, 7(1): 22.
|
[2] |
吴楚营,叶凯. 不同部位胃肠道间质瘤的腹腔镜手术策略[J/CD]. 中华普外科手术学杂志(电子版),2025, 19(02): 224-227.
|
[3] |
Valsangkar N, Sehdev A, Misra S, et al. Current management of gastrointestinal stromal tumors: Surgery, current biomarkers,mutations, and therapy [J]. Surgery, 2015, 158(5): 1149-1164.
|
[4] |
王峰,于恒,王萌,等. 中高危险度胃肠间质瘤患者术后治疗的预后分析[J/CD]. 中华普外科手术学杂志(电子版),2021,15(04): 460-463.
|
[5] |
杨宏,周雷,王文跃. 胃肠道间质瘤靶向治疗耐药性研究及对策[J]. 中华医学杂志,2012, 92(08): 572-575.
|
[6] |
林晨,王萌,管文贤,等. 胃肠间质瘤免疫疗法及新策略的研究进展[J/CD]. 中华普外科手术学杂志(电子版),2023,17(01): 98-100.
|
[7] |
Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor[J]. Hum Pathol, 2008, 39(10): 1411-1419.
|
[8] |
Khalikov DD, Akhmetzyanov FS, Petrov SV. Klinikomorfologicheskaia kharakteristika gastrointestinal’nykh stromal’nykh opukholeĭ [Clinical and morphological characteristics of gastrointestinal stromal tumors][J]. Arkh Patol, 2017, 79(4): 48-55.
|
[9] |
Kamarudin AN, Cox T, Kolamunnage-Dona R. Time-dependent ROC curve analysis in medical research: current methods and applications [J]. BMC Med Res Methodol, 2017, 17(1): 53.
|
[10] |
Joensuu H, Vehtari A, Riihimäki J, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts[J]. Lancet Oncol, 2012, 13(3): 265-274.
|
[11] |
Song DJ, Yang LT. [Advances in recurrence risk assessment of gastrointestinal stromal tumor][J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2022, 25(12): 1138-1143.
|
[12] |
Li J, Wang AR, Chen XD, et al. Ki67 for evaluating the prognosis of gastrointestinal stromal tumors: A systematic review and metaanalysis [J]. Oncol Lett, 2022, 23(6): 189.
|
[13] |
Yang J, Xing E, Zhang X, et al. Associations of CD34, Ki67, layer of invasion and clinical pathological characteristics, prognosis outcomes in gastrointestinal stromal tumors-a retrospective cohort study [J]. Transl Cancer Res, 2022, 11(8): 2866-2875.
|
[14] |
Joensuu H. KIT and PDGFRA Variants and the Survival of Patients with Gastrointestinal Stromal Tumor Treated with Adjuvant Imatinib [J]. Cancers (Basel), 2023, 15(15): 3879.
|
[15] |
Li XQ, Tu L, Wang M, et al. [Clinicopathological features and prognosis of gastrointestinal stromal tumor with PDGFRA-D842V mutation][J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2020, 23(9):872-879.
|
[16] |
Jia Q, Ma Z, Wang Y, et al. Integrated Single-Step Terahertz Metasensing for Simultaneous Detection Based on Exosomal Membrane Proteins Enables Pathological Typing of Gastric Cancer [J]. Research (Wash D C), 2025, 8: 0625.
|